Showing results (741-750 of 3,716) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|March 8, 2014
A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumorsColin D Weekes, Muralidhar Beeram, Anthony W Tolcher, et al.
Investigational New Drugs|August 1, 1991
Clinical use of thymidine as a rescue agent from methotrexate toxicityJ L Grem, S A King, J M Sorensen, et al.
Investigational New Drugs|May 1, 1991
Phase I studies of trimetrexate using single and weekly dose schedulesS D Huan, S S Legha, M N Raber, et al.
Investigational New Drugs|November 6, 2018
Pazopanib with low fat meal (PALM) in advanced renal cell carcinomaMelissa A Reimers, Maryann M Shango, Stephanie Daignault-Newton, et al.
Investigational New Drugs|November 2, 2018
A phase I study of the vascular endothelial growth factor inhibitor Vatalanib in combination with Pemetrexed disodium in patients with advanced solid tumorsFen Wang, Julian Molina, Daniel Satele, et al.
Investigational New Drugs|March 18, 2017
Human mass balance study and metabolite profiling of 14C-niraparib, a novel poly(ADP-Ribose) polymerase (PARP)-1 and PARP-2 inhibitor, in patients with advanced cancerLotte van Andel, Z Zhang, S Lu, et al.
Investigational New Drugs|March 13, 2017
Diclofenac sex-divergent drug-drug interaction with Sunitinib: pharmacokinetics and tissue distribution in male and female miceChii Chii Chew, Salby Ng, Yun Lee Chee, et al.
Investigational New Drugs|February 22, 2019
Synergistic effect and reduced toxicity by intratumoral injection of cytarabine-loaded hyaluronic acid hydrogel conjugates combined with radiotherapy on lung cancerJuan Tang, Na Wang, JingBo Wu, et al.
Investigational New Drugs|February 22, 2019
Phase I study of TAS-121, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, in patients with non-small-cell lung cancer harboring EGFR mutationsMakoto Nishio, Haruyasu Murakami, Yuichiro Ohe, et al.
Investigational New Drugs|March 2, 2019
Population pharmacokinetic analysis of AR-67, a lactone stable camptothecin analogue, in cancer patients with solid tumorsFei Tang, Eleftheria Tsakalozou, Susanne M Arnold, et al.
Pageof 372